These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28456674)

  • 1. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
    Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
    Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
    Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
    Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
    Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
    Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
    Carragee EJ; Hurwitz EL; Weiner BK
    Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
    Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
    Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
    Hiremath GK; Steinmetz MP; Krishnaney AA
    Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
    Tannoury CA; An HS
    Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
    Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
    J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
    [No Abstract]   [Full Text] [Related]  

  • 13. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Morphogenetic Proteins in Anterior Cervical Fusion: A Systematic Review and Meta-Analysis.
    Zadegan SA; Abedi A; Jazayeri SB; Nasiri Bonaki H; Jazayeri SB; Vaccaro AR; Rahimi-Movaghar V
    World Neurosurg; 2017 Aug; 104():752-787. PubMed ID: 28315798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
    Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
    Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human bone morphogenetic protein-2 versus iliac crest bone graft in anterior cervical discectomy and fusion: Dysphagia and dysphonia rates in the early postoperative period with review of the literature.
    Riederman BD; Butler BA; Lawton CD; Rosenthal BD; Balderama ES; Bernstein AJ
    J Clin Neurosci; 2017 Oct; 44():180-183. PubMed ID: 28716569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
    Hoffmann MF; Jones CB; Sietsema DL
    Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis.
    Klimo P; Peelle MW
    Spine J; 2009 Dec; 9(12):959-66. PubMed ID: 19574105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.